In a rat RA model, both circulating and skeletal muscle IGF-1 were decreased, the animals showed lower muscle mass, and subcutaneous injection of IGF-1 (100 μg/kg; twice daily for 12 days) increased body and hindlimb muscle weight without changing arthritis. Here, IGF1 is linked to arthritic joint disease.